Life Sciences & Health Innovation
Belgium has long been a global biopharma leader, punching far above its size and offering direct access to Europe’s largest markets. At the heart of this success, Wallonia stands out as a vibrant region where biotech, engineering, and health innovation converge with industrial excellence.
/--/uploads/sites/4/2025/12/AdobeStock_782854804.jpeg)
Belgium’s ranking in Europe
#1
for biotech aggregated market cap
#1
biopharma R&D spending
#2
for clinical trials
#3
for biopharma export
1. PWC 2024 ; 2. Pharma.be 2025 – all rankings in EU per capita, except ranking in export which is absolute.
Belgium accounts for just 2.7% of Europe’s population, yet it stands among the continent’s top performers in biopharma.
/--/uploads/sites/4/2025/12/vaccine.jpg)
There’s a good chance your medicines and vaccines come from Belgium
Belgium stands among the world’s biopharma powerhouses, representing 13% of EU’s biopharma exports. It leads Europe in biopharmaceutical R&D investment per capita—around €16 million every day—and ranks first for biotech market capitalisation, close to €50 billion.
The active presence of global pharma leaders have made Belgium a central hub for innovation, production, and exports in medicines and vaccines worldwide.
In Wallonia
50k
direct and indirect jobs in life sciences
#1
export industry of the region
5
universities and 11.000 researchers
4
life sciences hubs
/--/uploads/sites/4/2025/12/map_LS.jpg)
Wallonia, a mature life sciences & health ecosystem
Home to 300+ life sciences companies and sustained annual growth of 4.5%, Wallonia combines research excellence with industrial scale.
A recognized leader in biomanufacturing and nuclear medicine, the region exports advanced drug-substance production and radiopharma technologies to hospitals worldwide. Its fully integrated ecosystem — five universities, leading research centres, hospitals and specialized science parks — ensures a seamless path from discovery to commercialization.
With 100,000 m² (1.08 million sq ft) of ready-to-use lab space, CEIV Pharma-certified logistics, specialized supply chains and tailored funding and talent pipelines, Wallonia offers the ideal environment to transform innovation into global impact.
The Health cluster of Wallonia, accelerating Belgian health-tech & biopharma innovation
The Regional public investor, with a Life
B2H connects entrepreneurs to all the valuable resources and skills of the Liège life sciences ecosystem
A unique life sciences hub to start, connect, grow, and shape the future of health/--/uploads/sites/4/2026/01/areas-of-excellence.jpg)
/--/uploads/sites/4/2026/01/supply-chain.jpg)
/--/uploads/sites/4/2026/01/clinical-trials.jpg)
/--/uploads/sites/4/2026/01/lab-office.jpg)
/--/uploads/sites/4/2026/01/finance.jpg)
/--/uploads/sites/4/2026/01/development.jpg)
/--/uploads/sites/4/2026/02/Allegro01.jpeg)
/--/uploads/sites/4/2026/02/AdobeStock_734115192_Editorial_Use_Only.jpeg)
/--/uploads/sites/4/2026/02/AdobeStock_293584799.jpeg)
/--/uploads/sites/4/2026/02/AdobeStock_782880802.jpeg)
/--/uploads/sites/4/2026/02/AdobeStock_1758677468.jpeg)
/--/uploads/sites/4/2026/02/AdobeStock_1720601165.jpeg)
/--/uploads/sites/4/2026/02/AdobeStock_633895277.jpeg)
/--/uploads/sites/4/2026/01/DJI_0044.jpg)
/--/uploads/sites/4/2026/01/AdobeStock_395631955_Editorial_Use_Only.jpeg)
/--/uploads/sites/4/2026/01/Q1-Scientific-Cecile-Jacoby_video-cover_930_523_crop.jpg)